In vivo, anti-BCMA–anti-TACI CARs were able to have extended control of MM1S BCMA KO tumor in the stress model whereas anti-TACI–anti-BCMA CARs were not (Fig. 8b, c). This evidence concerns the gene TNFRSF17 and neoplasm.